IgM nephropathy: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = IgM nephropathy | |||
| image = [[File:IgM_scheme.svg|250px]] | |||
| caption = Schematic representation of IgM nephropathy | |||
| synonyms = Immunoglobulin M nephropathy | |||
| specialty = [[Nephrology]] | |||
| symptoms = [[Proteinuria]], [[hematuria]], [[edema]], [[hypertension]] | |||
| onset = Typically in [[childhood]] or [[young adulthood]] | |||
| duration = Chronic | |||
| causes = Unknown, possibly [[immune system]] dysfunction | |||
| risks = Family history, [[autoimmune disorders]] | |||
| diagnosis = [[Kidney biopsy]], [[urinalysis]], [[blood tests]] | |||
| differential = [[IgA nephropathy]], [[minimal change disease]], [[focal segmental glomerulosclerosis]] | |||
| treatment = [[Corticosteroids]], [[immunosuppressive therapy]], [[ACE inhibitors]], [[ARBs]] | |||
| prognosis = Variable, can lead to [[chronic kidney disease]] | |||
| frequency = Rare | |||
}} | |||
{{Short description|A kidney disorder characterized by the presence of IgM antibodies in the glomeruli}} | {{Short description|A kidney disorder characterized by the presence of IgM antibodies in the glomeruli}} | ||
'''IgM nephropathy''' is a kidney disorder characterized by the presence of [[immunoglobulin M]] (IgM) antibodies in the [[glomeruli]], which are the filtering units of the [[kidney]]. This condition is considered a form of [[glomerulonephritis]], a group of diseases that cause inflammation of the glomeruli. | '''IgM nephropathy''' is a kidney disorder characterized by the presence of [[immunoglobulin M]] (IgM) antibodies in the [[glomeruli]], which are the filtering units of the [[kidney]]. This condition is considered a form of [[glomerulonephritis]], a group of diseases that cause inflammation of the glomeruli. | ||
==Pathophysiology== | ==Pathophysiology== | ||
IgM nephropathy is marked by the deposition of IgM antibodies in the mesangial areas of the glomeruli. The exact mechanism by which IgM contributes to kidney damage is not fully understood. However, it is believed that the presence of IgM may activate the [[complement system]], leading to inflammation and damage to the glomerular structure. This can result in impaired kidney function and proteinuria, where excess protein is found in the urine. | IgM nephropathy is marked by the deposition of IgM antibodies in the mesangial areas of the glomeruli. The exact mechanism by which IgM contributes to kidney damage is not fully understood. However, it is believed that the presence of IgM may activate the [[complement system]], leading to inflammation and damage to the glomerular structure. This can result in impaired kidney function and proteinuria, where excess protein is found in the urine. | ||
==Clinical Presentation== | ==Clinical Presentation== | ||
Patients with IgM nephropathy may present with a variety of symptoms, including: | Patients with IgM nephropathy may present with a variety of symptoms, including: | ||
| Line 14: | Line 27: | ||
* [[Hypertension]] | * [[Hypertension]] | ||
* Edema | * Edema | ||
The severity of symptoms can vary widely among individuals. Some patients may have mild symptoms, while others may progress to more severe kidney damage. | The severity of symptoms can vary widely among individuals. Some patients may have mild symptoms, while others may progress to more severe kidney damage. | ||
==Diagnosis== | ==Diagnosis== | ||
The diagnosis of IgM nephropathy is typically made through a [[kidney biopsy]]. Under a microscope, the biopsy will show mesangial deposits of IgM antibodies. Immunofluorescence microscopy is often used to confirm the presence of IgM in the glomeruli. | The diagnosis of IgM nephropathy is typically made through a [[kidney biopsy]]. Under a microscope, the biopsy will show mesangial deposits of IgM antibodies. Immunofluorescence microscopy is often used to confirm the presence of IgM in the glomeruli. | ||
==Treatment== | ==Treatment== | ||
Treatment for IgM nephropathy is not standardized and can vary depending on the severity of the disease. Common approaches include: | Treatment for IgM nephropathy is not standardized and can vary depending on the severity of the disease. Common approaches include: | ||
| Line 25: | Line 35: | ||
* [[Immunosuppressive drugs]] | * [[Immunosuppressive drugs]] | ||
* [[Angiotensin-converting enzyme inhibitors]] (ACE inhibitors) or [[angiotensin II receptor blockers]] (ARBs) to control blood pressure and reduce proteinuria | * [[Angiotensin-converting enzyme inhibitors]] (ACE inhibitors) or [[angiotensin II receptor blockers]] (ARBs) to control blood pressure and reduce proteinuria | ||
==Prognosis== | ==Prognosis== | ||
The prognosis for patients with IgM nephropathy varies. Some individuals may experience a benign course with minimal kidney damage, while others may progress to chronic kidney disease or even [[end-stage renal disease]]. Regular monitoring and management of symptoms are crucial to improving outcomes. | The prognosis for patients with IgM nephropathy varies. Some individuals may experience a benign course with minimal kidney damage, while others may progress to chronic kidney disease or even [[end-stage renal disease]]. Regular monitoring and management of symptoms are crucial to improving outcomes. | ||
==See also== | |||
== | |||
* [[Glomerulonephritis]] | * [[Glomerulonephritis]] | ||
* [[Nephrotic syndrome]] | * [[Nephrotic syndrome]] | ||
* [[Chronic kidney disease]] | * [[Chronic kidney disease]] | ||
[[Category:Kidney diseases]] | [[Category:Kidney diseases]] | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
Latest revision as of 02:42, 6 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| IgM nephropathy | |
|---|---|
| File:IgM scheme.svg | |
| Synonyms | Immunoglobulin M nephropathy |
| Pronounce | N/A |
| Specialty | Nephrology |
| Symptoms | Proteinuria, hematuria, edema, hypertension |
| Complications | N/A |
| Onset | Typically in childhood or young adulthood |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown, possibly immune system dysfunction |
| Risks | Family history, autoimmune disorders |
| Diagnosis | Kidney biopsy, urinalysis, blood tests |
| Differential diagnosis | IgA nephropathy, minimal change disease, focal segmental glomerulosclerosis |
| Prevention | N/A |
| Treatment | Corticosteroids, immunosuppressive therapy, ACE inhibitors, ARBs |
| Medication | N/A |
| Prognosis | Variable, can lead to chronic kidney disease |
| Frequency | Rare |
| Deaths | N/A |
A kidney disorder characterized by the presence of IgM antibodies in the glomeruli
IgM nephropathy is a kidney disorder characterized by the presence of immunoglobulin M (IgM) antibodies in the glomeruli, which are the filtering units of the kidney. This condition is considered a form of glomerulonephritis, a group of diseases that cause inflammation of the glomeruli.
Pathophysiology[edit]
IgM nephropathy is marked by the deposition of IgM antibodies in the mesangial areas of the glomeruli. The exact mechanism by which IgM contributes to kidney damage is not fully understood. However, it is believed that the presence of IgM may activate the complement system, leading to inflammation and damage to the glomerular structure. This can result in impaired kidney function and proteinuria, where excess protein is found in the urine.
Clinical Presentation[edit]
Patients with IgM nephropathy may present with a variety of symptoms, including:
- Proteinuria
- Hematuria
- Hypertension
- Edema
The severity of symptoms can vary widely among individuals. Some patients may have mild symptoms, while others may progress to more severe kidney damage.
Diagnosis[edit]
The diagnosis of IgM nephropathy is typically made through a kidney biopsy. Under a microscope, the biopsy will show mesangial deposits of IgM antibodies. Immunofluorescence microscopy is often used to confirm the presence of IgM in the glomeruli.
Treatment[edit]
Treatment for IgM nephropathy is not standardized and can vary depending on the severity of the disease. Common approaches include:
- Corticosteroids to reduce inflammation
- Immunosuppressive drugs
- Angiotensin-converting enzyme inhibitors (ACE inhibitors) or angiotensin II receptor blockers (ARBs) to control blood pressure and reduce proteinuria
Prognosis[edit]
The prognosis for patients with IgM nephropathy varies. Some individuals may experience a benign course with minimal kidney damage, while others may progress to chronic kidney disease or even end-stage renal disease. Regular monitoring and management of symptoms are crucial to improving outcomes.
